Prospective Multicentre Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Iloprost (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms IVENT
- Sponsors Bayer
- 22 Sep 2017 Planned End Date changed from 31 Aug 2017 to 30 Nov 2017.
- 22 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 16 Mar 2017 Planned End Date changed from 1 May 2017 to 31 Aug 2017.